Gene evaluation for antihypertensive drug effects study
Not Applicable
- Conditions
- essential hypertension
- Registration Number
- JPRN-C000000119
- Lead Sponsor
- ational Cardiovascular Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
severe hypertension (more than 180 and/or 110 mmHg) secondary hypertension female with pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method gene polymorphisms relating to blood pressure lowering effect of thiazide diuretics, calcium channel blocker, angiotensin II receptor blocker
- Secondary Outcome Measures
Name Time Method gene polymorphisms relating to side effects of thiazide diuretics, calcium channel blocker, angiotensin II receptor blocker